SF
HZNP

Synovus Financial’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Synovus Financial’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,973
Closed -$907K – 890
2022
Q4 		$907K Sell
7,973
-1,826
-19% -$152K 0.01% 480
2022
Q3 		$607K Buy
9,799
+596
+6% +$41.6K 0.01% 532
2022
Q2 		$730K Sell
9,203
-1,993
-18% -$189K 0.01% 486
2022
Q1 		$1.18M Buy
11,196
+895
+9% +$87.2K 0.01% 415
2021
Q4 		$1.11M Buy
10,301
+189
+2% +$20.6K 0.01% 427
2021
Q3 		$1.1M Sell
10,112
-4,316
-30% -$448K 0.01% 410
2021
Q2 		$1.34M Sell
14,428
-940
-6% -$86.5K 0.01% 361
2021
Q1 		$1.41M Sell
15,368
-353
-2% -$29.8K 0.02% 314
2020
Q4 		$1.14M Buy
15,721
+446
+3% +$33.2K 0.01% 350
2020
Q3 		$1.18M Buy
15,275
+296
+2% +$20.4K 0.02% 330
2020
Q2 		$833K Sell
14,979
-2,096
-12% -$89.7K 0.01% 360
2020
Q1 		$503K Buy
17,075
+4,112
+32% +$139K 0.01% 512
2019
Q4 		$472K Sell
12,963
-2,473
-16% -$75.8K 0.01% 483
2019
Q3 		$418K Buy
15,436
+15,258
+8,572% +$395K 0.01% 497
2019
Q2 		$4K Hold
178
– – ﹤0.01% 1275
2019
Q1 		$5K Hold
178
– – ﹤0.01% 1240
2018
Q4 		$3K Hold
178
– – ﹤0.01% 1298
2018
Q3 		$3K Buy
+178
New +$3.38K ﹤0.01% 1316

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Synovus Financial's HZNP Position: Q1 2023 in Review

Synovus Financial sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 7,973 shares — an estimated $907K sold.

Synovus Financial first reported a position in HZNP in Q3 2018 and held it in 18 quarters. The position peaked at $1.41M in Q1 2021. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

  • Synovus Financial reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Synovus Financial sold 7,973 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $907K.
  • Synovus Financial first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2018 and held it in 18 quarters.
  • Synovus Financial's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.41M in Q1 2021.
  • 553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Synovus Financial's 13F filing for Q1 2023, filed 11 May 2023.